Brief: Initiator Pharma Gets Approval To Start Phase 2a Trial For IP2018

Initiator Pharma A/S

29/06/2020 09:35

June 29 (Reuters) - Initiator Pharma A/S  INIT.TE :
    * INITIATOR PHARMA OBTAINS APPROVAL TO START PHASE 2A TRIAL
FOR
IP2018
    * IP2018. PHASE 2A CLINICAL TRIAL IS PLANNED TO BE INITIATED
IN Q3
2020
    * PENDING COVID-19 SITUATION TRIAL IS PLANNED TO START IN Q3
2020
AND TOP-LINE DATA IS EXPECTED END OF FIRST HALF YEAR OF 2021

Source text for Eikon:  ID:nWkr19Ml4q 
Further company coverage:  INIT.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))